US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
USOTC
Covalon Technologies Ltd (QX) (CVALF)
Covalon Technologies Ltd (QX) (CVALF) ニュース

Covalon Technologies Ltd (QX) (CVALF)

1.5162

-0.0438

(-2.81%)

終了 6月7日 5:00AM

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

Covalon Technologies Reports Significant Milestones Spanning Vascular Access, Infection Prevention, and Wound Care

Covalon Technologies Ltd. (TSX: COV; OTCQX: CVALF), an advanced medical technologies company, today announced a series of important milestones...

Covalon to Showcase Clinical Innovation and Infection Prevention Leadership at Infusion Nurses Society 2026 Annual Meeting

Covalon Technologies Ltd. (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its upcoming presence at the...

Covalon Honoured to Partner with the Association for Vascular Access and Global Expert Dr. Nancy Moureau to Tackle Critical IV Therapy Complications

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company focused on improving...

Empowering Nurses with Innovation: Covalon Showcases Patient Safety Solutions to Tackle Preventable Complications at ANCC National Magnet & Pathway Conference

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company focused on improving...

Covalon Presents Evidence-Backed Innovations Making a Difference for Critically Ill Children at APHON

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, announced its...

Evidence-Driven Outcomes and Clinical Innovation Highlight Covalon’s Presence at the Association for Vascular Access 2025 Annual Meeting

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, announced its...

Covalon Announces Publication of Impactful VALGuard® Line Guard Clinical Study Demonstrating Significant Reduction in Central Line-Associated Blood Stream Infections (CLABSIs)

Peer-reviewed study reports a 78% reduction in hospital-wide CLABSI rates from 2023 to 2024 Covalon Technologies Ltd. (the "Company" or...

stocktrademan

stocktrademan 9年前

CVALF buy 3.4469

Covalon Technologies Ltd.

1660 Tech Avenue
Unit 5
Mississauga, ON L4W 5S7
Canada
905-568-8400

http://www.covalon.com

Covalon uses science and technology to help solve major medical challenges associated with prevention, detection and management of areas such as infection, tissue repair, medical device biocompatibility, and condition management.

Together, our technology platforms, wound care products, and consulting services deliver a suite of cost-effective solutions to help our customers achieve product differentiation through improved patient outcomes.

normal chart

log chart

Covalon Technologies (QX)

Kismet Acquisition Two

Super League Enterprise

Minera IRL (PK)

Awale Resources

US Dollar vs BTN

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。